Page last updated: 2024-08-22

isopentenyladenosine and Hutchinson Gilford Progeria Syndrome

isopentenyladenosine has been researched along with Hutchinson Gilford Progeria Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bifulco, M; Caruso, MG; D'Alessandro, A; Laezza, C; Malfitano, AM; Notarnicola, M; Paladino, S1

Other Studies

1 other study(ies) available for isopentenyladenosine and Hutchinson Gilford Progeria Syndrome

ArticleYear
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
    The FEBS journal, 2013, Volume: 280, Issue:23

    Topics: Adolescent; Adult; Blotting, Western; Cell Nucleus; Cells, Cultured; Child; Fibroblasts; Geranyltranstransferase; Humans; Immunoprecipitation; Isopentenyladenosine; Lamin Type A; Male; Microscopy, Fluorescence; Nuclear Proteins; Plant Growth Regulators; Progeria; Protein Precursors; Protein Prenylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2013